Amrize Ltd (NYSE:AMRZ – Get Free Report) CTO Roald Brouwer bought 1,500 shares of the firm’s stock in a transaction on Thursday, May 21st. The shares were bought at an average cost of $49.84 per share, for a total transaction of $74,760.00. Following the purchase, the chief technology officer owned 19,757 shares of the company’s stock, valued at approximately $984,688.88. The trade was a 8.22% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Roald Brouwer also recently made the following trade(s):
- On Friday, March 13th, Roald Brouwer purchased 2,000 shares of Amrize stock. The stock was purchased at an average price of $54.88 per share, with a total value of $109,760.00.
- On Wednesday, March 11th, Roald Brouwer acquired 3,000 shares of Amrize stock. The shares were purchased at an average cost of $58.72 per share, for a total transaction of $176,160.00.
Amrize Price Performance
AMRZ stock traded up $0.27 during midday trading on Thursday, reaching $50.27. 2,020,258 shares of the stock were exchanged, compared to its average volume of 3,138,242. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94. The company has a fifty day moving average price of $55.12 and a 200 day moving average price of $55.13. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The stock has a market capitalization of $27.80 billion and a PE ratio of 24.05.
Amrize Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is 21.05%.
Wall Street Analyst Weigh In
A number of research firms have weighed in on AMRZ. Royal Bank Of Canada reduced their target price on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a report on Friday, May 1st. Oppenheimer set a $68.00 price target on shares of Amrize in a research note on Friday, May 1st. Citigroup reduced their price objective on shares of Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Truist Financial decreased their price objective on Amrize from $75.00 to $65.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Weiss Ratings lowered Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $64.86.
Get Our Latest Research Report on AMRZ
Institutional Investors Weigh In On Amrize
Institutional investors have recently modified their holdings of the company. MCF Advisors LLC bought a new position in Amrize during the fourth quarter worth $27,000. State of Wyoming bought a new stake in Amrize during the third quarter valued at $32,000. Basepoint Wealth LLC acquired a new stake in Amrize during the 4th quarter worth about $33,000. Laurel Wealth Advisors LLC acquired a new stake in Amrize during the 4th quarter worth about $34,000. Finally, US Bancorp DE bought a new position in shares of Amrize in the 3rd quarter worth about $38,000.
About Amrize
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
- 2 Software Stocks Turning AI Fears Into Fundamental Gains
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
